Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen C Bain

Showing results (81-90 of 129) with videos related to

Pageof 13
Sort By:
Diabetes Care|March 22, 2013
Large pre- and postexercise rapid-acting insulin reductions preserve glycemia and prevent early- but not late-onset hypoglycemia in patients with type 1 diabetesMatthew D Campbell, Mark Walker, Michael I Trenell, et al.
Diabetes, Obesity & Metabolism|December 9, 2022
Metabolic and physiological responses to graded exercise testing in individuals with type 1 diabetes using insulin pump therapyOlivia M McCarthy, Kasper Birch Kristensen, Merete Bechmann Christensen, et al.
Clinical Obesity|February 8, 2021
Costs of the COVID-19 pandemic associated with obesity in Europe: A health-care cost modelSebastien Czernichow, Stephen C Bain, Matthew Capehorn, et al.
Journal of Diabetes Science and Technology|October 10, 2017
Acceptability of Implantable Continuous Glucose Monitoring SensorKatharine D Barnard, Jort Kropff, Pratik Choudhary, et al.
Diabetologia|July 10, 2024
Efficacy and safety of oral semaglutide vs sitagliptin in a predominantly Chinese population with type 2 diabetes uncontrolled with metformin: PIONEER 12, a double-blind, Phase IIIa, randomised trialLinong Ji, Rikke M Agesen, Stephen C Bain, et al.
Diabetes Care|December 19, 2015
Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL): A Randomized Clinical TrialMelanie J Davies, Stephen C Bain, Stephen L Atkin, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 29, 2022
Defining the Role of SGLT2 Inhibitors in Primary Care: Time to Think DifferentlyMarc Evans, Angharad R Morgan, Stephen C Bain, et al.
Diabetes, Obesity & Metabolism|July 24, 2019
Performance of the Freestyle Libre flash glucose monitoring (flash GM) system in individuals with type 1 diabetes: A secondary outcome analysis of a randomized crossover trialOthmar Moser, Max L Eckstein, Olivia McCarthy, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 19, 2022
Meeting the Challenge of Virtual Diabetes Care: A Consensus Viewpoint on the Positioning and Value of Oral Semaglutide in Routine Clinical PracticeMarc Evans, Angharad R Morgan, Stephen C Bain, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 22, 2022
Ageing well with diabetes: A workshop to co-design research recommendations for improving the diabetes care of older peopleThomas A F Wylie, Anna Morris, Elizabeth Robertson, et al.
Pageof 13

Showing results (81-90 of 129) with videos related to

Sort By:
Pageof 13
Diabetes Care|March 22, 2013
Large pre- and postexercise rapid-acting insulin reductions preserve glycemia and prevent early- but not late-onset hypoglycemia in patients with type 1 diabetesMatthew D Campbell, Mark Walker, Michael I Trenell, et al.
Diabetes, Obesity & Metabolism|December 9, 2022
Metabolic and physiological responses to graded exercise testing in individuals with type 1 diabetes using insulin pump therapyOlivia M McCarthy, Kasper Birch Kristensen, Merete Bechmann Christensen, et al.
Clinical Obesity|February 8, 2021
Costs of the COVID-19 pandemic associated with obesity in Europe: A health-care cost modelSebastien Czernichow, Stephen C Bain, Matthew Capehorn, et al.
Journal of Diabetes Science and Technology|October 10, 2017
Acceptability of Implantable Continuous Glucose Monitoring SensorKatharine D Barnard, Jort Kropff, Pratik Choudhary, et al.
Diabetologia|July 10, 2024
Efficacy and safety of oral semaglutide vs sitagliptin in a predominantly Chinese population with type 2 diabetes uncontrolled with metformin: PIONEER 12, a double-blind, Phase IIIa, randomised trialLinong Ji, Rikke M Agesen, Stephen C Bain, et al.
Diabetes Care|December 19, 2015
Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL): A Randomized Clinical TrialMelanie J Davies, Stephen C Bain, Stephen L Atkin, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 29, 2022
Defining the Role of SGLT2 Inhibitors in Primary Care: Time to Think DifferentlyMarc Evans, Angharad R Morgan, Stephen C Bain, et al.
Diabetes, Obesity & Metabolism|July 24, 2019
Performance of the Freestyle Libre flash glucose monitoring (flash GM) system in individuals with type 1 diabetes: A secondary outcome analysis of a randomized crossover trialOthmar Moser, Max L Eckstein, Olivia McCarthy, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 19, 2022
Meeting the Challenge of Virtual Diabetes Care: A Consensus Viewpoint on the Positioning and Value of Oral Semaglutide in Routine Clinical PracticeMarc Evans, Angharad R Morgan, Stephen C Bain, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 22, 2022
Ageing well with diabetes: A workshop to co-design research recommendations for improving the diabetes care of older peopleThomas A F Wylie, Anna Morris, Elizabeth Robertson, et al.
Pageof 13